Clinical trial · Observational
Surgical and Functional Outcomes of Rectourethral Fistulas Surgery With Gracilis Flap Interposition After Localized Prostatic Cancer Treatment.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prostate cancer is the first cancer amongst men with more than 50000 cases per year in France. Surgical, radiation, frost, or ultrasound induced rectourethral fistula is a rare complication (\<1%) of localized prostatic cancer treatment but hard to manage. Different types of treatment exist: conservatory, trans-sphinteric (York-Masson), transanal, perineal, with or without muscle flap interposition. Gracilis flap interposition for rectourethral fistula management is a promising technique but few cases are described and functional results are scarce. The aim of this study is to present surgical and functional outcomes of rectourethral fistulas surgery with gracilis flap interposition after treatment of localized prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectourethral Fistula | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gracilis flap interposition for rectouretral fistula management | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Localized prostate cancer treatment induced rectourethral fistula
- description
- Every patient over 18 years old operated for closure of a rectourethral fistula with gracilis flap interposition after localized prostatic cancer treatment (Radiotherapy, surgery, cryotherapy and HIFU).
- interventionNames
- Procedure: Gracilis flap interposition for rectouretral fistula management
Primary outcomes (5)
- measure
- Urinary continence
- timeFrame
- 3 months after surgery
- description
- Urinary Symptom Profile form (from 0 to 39), a higher score indicating a worse outcome.
- measure
- Fecal continence
- timeFrame
- 3 months after surgery
- description
- St. Marks form (from 0 to 26), a higher score indicating a worse outcome.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male over 18 years old * Treated for a localized prostatic cancer (Prostatectomy, cryotherapy, HIFU, radiotherapy) * Affected with a treatment induced Rectourethral fistula Exclusion Criteria: * Rectourethral fistula caused by other pelvic diseases (gynecological or digestif cancer, inflammatory bowel disease, other urogenital issues) * Rectourethral fistula treated by cysto-prostatectomy with urinary tract derivation * Patient under guardianship * Non comprehension of written or spoken French
References
Publications (0)
Data not yet available